Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>Curcumae Rhizoma-<em>Sparganii Rhizoma</em> (CR-SR), an ancient and classical herbal couple, has been extensively used for tumor treatment in clinic of traditional Chinese medicines (TCMs).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim of the study</h3><p>The study aimed to uncover the anti-tumor active materials of CR-SR water decoction (CR:SR = 1:1) via an integrated approach of spectrum-effect relationship, molecular docking, and ADME evaluation.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>The anti-tumor activities toward A549, HepG2, Hela, BGC-823, and MCF-7 cells of the different polar elution fractions (DPEFs) of CR, SR, and CR-SR were determined by Cell Counting Kit-8 (CCK-8) assay. Likewise, the DPEFs' combinations of CR and SR were also tested. The chemical fingerprints of these fractions were profiled by HPLC. Meanwhile, HPLC-ESI-Q-TOF-MS/MS was applied for the identification of chemical components. The main effect-related compounds were screened out by spectrum-effect relationship and molecular docking method. The oral bioavailability and druggability of these active components were subsequently evaluated. Finally, five monomeric compounds were validated experimentally using HepG2 cells.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The 80% ethanol elution fraction of CR, SR, and CR-SR showed strong anti-tumor effects toward five cells. Also, the combinations with the 80% ethanol elution fraction of CR and SR showed stronger tumor inhibition effects among the DPEFs' combinations of CR and SR. By spectrum-effect relationship, HPLC-MS, and molecular docking analysis, 24 main effect-related compounds seemed to have potential anti-tumor effects. ADME evaluation showed rutin performed low oral bioavailability and druggability. Therefore, we suppose that 23 compounds (including 4 unknown compounds) are the primary anti-tumor active components of CR-SR water decoction. Among them, zederone, curcumol, chlorogenic acid, calycosin, and curcumenol were validated successfully with good tumor inhibition effects.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>In summary, this study demonstrated that the multi-components of CR-SR contribute to its anti-tumor effects. It established a rapid and useful strategy to explore the active material basis of traditional Chinese herbal couples with a multi-technology integrated approach in practice, including chromatography, mass spectrometry, machine algorithm models, online databases, and <em>in vitro</em> cell experiments.</p>

Feature Selection for the Identification of Antitumor Compounds in the Alcohol Total Extracts of Curcuma Longa.

Identification of antitumor constituents in curcuminoids from Curcuma longa L. based on the composition-activity relationship.

Bioassay-guided Separation and Identification of the Anticancer Composition from Curcuma Longa L. by the Combination Strategy of Methanol Gradient Countercurrent Chromatography and Ultra-High-performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry

HPLC-MS and GC-MS Analyses Combined with Orthogonal Partial Least Squares to Identify Cytotoxic Constituents from Turmeric (curcuma Longa L.).

Biochemometric approach combined with 1D CSSF-TOCSY for the identification of sensitization agents in Curcuma longa L. and prediction of their action mechanisms

Chemical Analysis of the Chinese Herbal Medicine Turmeric (curcuma Longa L.)

Chemical Markers' Knockout Coupled with UHPLC-HRMS-based Metabolomics Reveals Anti-Cancer Integration Effects of the Curcuminoids of Turmeric (curcuma Longa L.) on Lung Cancer Cell Line.

An integrated approach to uncover anti-tumor active materials of Curcumae Rhizoma-Sparganii Rhizoma based on spectrum-effect relationship, molecular docking, and ADME evaluation

Composition–activity Relationship Modeling to Predict the Antitumor Activity for Quality Control of Curcuminoids from Curcuma Longa L. (Turmeric)

A Novel Approach to Evaluate the Quality and Identify the Active Compounds of the Essential Oil from Curcuma Longa L.

Identification of the Material Basis of the Medicinal Properties in Curcuma Longa L. to Enhance Targeted Clinical Application

Lvsiyujins A-G, new sesquiterpenoids, from Curcuma phaeocaulis Valeton root tuber and their preliminary pharmacological property assessment based on ADME evaluation, molecular docking and in vitro experiments

Integration of Two-Dimensional Liquid Chromatography-Mass Spectrometry and Molecular Docking to Characterize and Predict Polar Active Compounds in <i>Curcuma kwangsiensis</i>

Anti-inflammatory, Antioxidant and Antitumor Activities of Ingredients of Curcuma Phaeocaulis Val

Variation on Composition and Bioactivity of Essential Oils of Four Common Curcuma Herbs

Separation and identification of terpene‐conjugated curcuminoids based on LC‐MS/MS and their in vitro anti‐inflammatory activities

Sesquiterpenoids isolated from the rhizome of <i>Curcuma phaeocaulis</i> Valeton: antitumor activity, in silico molecular docking and molecular dynamics study

Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs

Molecular Mechanism of Turmeric in the Treatment of Liver Cancer Based on Network Pharmacology

Anticancer potential of turmeric (Curcuma longa) ethanol extract and prediction of its mechanism through the Akt1 pathway

Chemical Composition of Turmeric (Curcuma longa L.) Ethanol Extract and Its Antimicrobial Activities and Free Radical Scavenging Capacities